May 5, 2026
Coforge reports quarter ended March 31, 2026 revenue of 44,504
Coforge Limited — quarter ended March 31, 2026 (audited) and year ended March 31, 2026 (audited) S. No. Name of the Entity 1 Coforge Limited 2...
Copy-Pasta
Posts that have clean copy-paste-able results from quarterly results of Indian companies
May 5, 2026
GNG Electronics Q1 FY26 profit jumps to ₹121.31 crore
GNG Electronics Limited — quarter ended March 31, 2026 (audited/unaudited as stated) Particulars Quarter ended Mar 31 2026 Unaudited Dec 31 2025 Unaudited Mar 31 2025...
May 5, 2026
Jammu & Kashmir Bank: Deposits up to ₹1.65 lakh crore
Jammu and Kashmir Bank Limited — Quarter and financial year ended 31 March 2026 Schedule Capital and Liabilities / Assets As at 31.03.2026 (AUDITED) As at...
May 5, 2026
SRF Limited Q1 FY26: Net profit up to Rs 507 crore
SRF LIMITED — Quarter and year ended 31-Mar-2026 (Standalone & Consolidated) Optional commentary: Standalone financial results (Rs. in Crores; except per share data). S.No. Particulars Quarter...
May 5, 2026
GHCL Q1 FY26 Net Profit Falls to ₹119.97 crore
GHCL Limited — Quarter ended March 31, 2026; Year ended March 31, 2026 S. No. Particulars Quarter Ended Year Ended 31.03.2026 Audited (Refer Note 7) 31.12.2025...
May 5, 2026
Ajanta Pharma Q4 Revenue Jumps to ₹1,422 crore
Ajanta Pharma Limited — Quarter ended 31 March 2026 (FY ended 31 March 2026) Milestone Value Revenue crosses 5,000 cr. PAT crosses 1,000 cr. EBITDA close...
May 5, 2026
DCW Limited Reappoints Auditors for FY 2026-27
DCW LIMITED — Quarter and year ended 31st March, 2026 Sr. No. Particulars M/s. PKF Sridhar & Santhanam LLP (Internal Auditors) M/s. R. Nanabhoy and Co....
May 5, 2026
Kisan Mouldings posts Q1 FY26 loss, EPS -0.28
Kisan Mouldings Ltd. — Quarter and year ended March 31, 2026 Particulars Quarter ended March 31, 2026 (Audited) (Refer note 3) Quarter ended December 31, 2025...
May 5, 2026
Sayaji Industries Q4 FY26 profit jumps to ₹1,156 crore
Sayaji Industries Limited — Quarter and year ended March 31, 2026 Particulars Quarter ended Year ended March 31, 2026 (Audited) Dec 31, 2025 (Unaudited) March 31,...
May 5, 2026
Emcure Pharmaceuticals Revenue Rose to ₹24,697 Cr
Emcure Pharmaceuticals Limited — Quarter and year ended March 31, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, Bandra Kurla...